Fortress Biotech, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Harvey Jimmie | — | Award / Grant | 100,000 | — | — | 950,000 | Jan 1, 2023 |
| Lu Lucy | — | Award / Grant | 30,000 | — | — | 71,403 | Dec 16, 2022 |
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Purchase | 100,000 | $0.68 | $68,000 | 11,730,324 | Dec 1, 2022 |
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Purchase | 5,000 | $0.56 | $2,800 | 11,630,324 | Nov 30, 2022 |
| Jin David | Chief Financial Officer | Purchase | 5,000 | $0.56 | $2,800 | 1,402,829 | Nov 30, 2022 |
| Jin David | Chief Financial Officer | Award / Grant | 1,350,000 | — | — | 1,397,829 | Oct 26, 2022 |
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Purchase | 100,000 | $0.70 | $70,000 | 11,625,324 | Oct 21, 2022 |
| WEISS MICHAEL S | See Remarks | Award / Grant | 1,102,986 | — | — | 12,335,136 | Jan 1, 2022 |
| Lorenz Kevin | — | Award / Grant | 50,000 | — | — | 264,572 | Jan 1, 2022 |
| Harvey Jimmie | — | Award / Grant | 100,000 | — | — | 850,000 | Jan 1, 2022 |
| LOBELL J JAY | — | Award / Grant | 100,000 | — | — | 1,236,000 | Jan 1, 2022 |
| Rowinsky Eric K | — | Award / Grant | 100,000 | — | — | 820,000 | Jan 1, 2022 |
| Hoenlein Malcolm | — | Other | 406 | — | — | 435,406 | Nov 16, 2021 |
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Award / Grant | 1,297 | $2.31 | $2,996 | 10,408,336 | Sep 30, 2021 |
| Hunter Robyn | Chief Financial Officer | Sale | 28,292 | $3.13 | $88,554 | 163,877 | Sep 21, 2021 |
| Klein Dov | — | Other | 480 | — | — | 655,785 | Aug 5, 2021 |
| Rowinsky Eric K | — | Sale | 8,000 | $4.31 | $34,480 | 730,000 | Feb 18, 2021 |
| WEISS MICHAEL S | See Remarks | Award / Grant | 1,030,339 | — | — | 11,232,150 | Jan 1, 2021 |
| Lorenz Kevin | — | Purchase | 50,000 | — | — | 214,582 | Jan 1, 2021 |
| LOBELL J JAY | — | Award / Grant | 100,000 | — | — | 1,136,000 | Jan 1, 2021 |
| Klein Dov | — | Award / Grant | 100,000 | — | — | 655,000 | Jan 1, 2021 |
| Hoenlein Malcolm | — | Award / Grant | 50,000 | — | — | 435,000 | Jan 1, 2021 |
| Harvey Jimmie | — | Award / Grant | 100,000 | — | — | 750,000 | Jan 1, 2021 |
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Award / Grant | 1,602 | $1.69 | $2,707 | 9,375,450 | Dec 1, 2020 |
| Hunter Robyn | Chief Financial Officer | Sale | 28,450 | $4.38 | $124,611 | 192,169 | Sep 22, 2020 |
| Hoenlein Malcolm | — | Purchase | 16,667 | $18.00 | $300,006 | 16,667 | Aug 26, 2020 |
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Purchase | 52,500 | $18.00 | $945,000 | 92,500 | Aug 26, 2020 |
| WEISS MICHAEL S | EXECUTIVE VICE CHAIRMAN | Award / Grant | 801,536 | — | — | 10,201,811 | Jan 1, 2020 |
| Rowinsky Eric K | — | Award / Grant | 100,000 | — | — | 650,000 | Jan 1, 2020 |
| Lorenz Kevin | — | Purchase | 50,000 | — | — | 164,582 | Jan 1, 2020 |
| LOBELL J JAY | — | Award / Grant | 100,000 | — | — | 1,036,000 | Jan 1, 2020 |
| Klein Dov | — | Award / Grant | 100,000 | — | — | 555,000 | Jan 1, 2020 |
| Hoenlein Malcolm | — | Award / Grant | 50,000 | — | — | 385,000 | Jan 1, 2020 |
| Harvey Jimmie | — | Award / Grant | 100,000 | — | — | 650,000 | Jan 1, 2020 |
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Award / Grant | 396,825 | $1.26 | $500,000 | 8,569,722 | Jul 18, 2019 |
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Purchase | 1,123 | $2.06 | $2,313 | 8,572,312 | Jun 3, 2019 |
| Hunter Robyn | Chief Financial Officer | Purchase | 2,297 | $1.10 | $2,527 | 220,619 | Jun 3, 2019 |
| ROSENWALD LINDSAY A MD | PRESIDENT AND CEO | Award / Grant | 586,428 | — | — | 7,358,706 | Jan 1, 2019 |
| LOBELL J JAY | — | Award / Grant | 100,000 | — | — | 936,000 | Jan 1, 2019 |
| Hoenlein Malcolm | — | Award / Grant | 50,000 | — | — | 335,000 | Jan 1, 2019 |
| Harvey Jimmie | — | Award / Grant | 100,000 | — | — | 550,000 | Jan 1, 2019 |
| Rowinsky Eric K | — | Award / Grant | 100,000 | — | — | 550,000 | Jan 1, 2019 |
| Avgerinos George | SVP, BIOLOGICS OPERATIONS | Sale | 97,325 | $1.05 | $102,191 | 255,170 | Dec 11, 2018 |
| Avgerinos George | SVP, BIOLOGICS OPERATIONS | Award / Grant | 400,000 | — | — | 655,170 | Dec 11, 2018 |
| Hunter Robyn | Chief Financial Officer | Sale | 20,370 | $1.29 | $26,277 | 239,759 | Nov 23, 2018 |
| Hoenlein Malcolm | — | Award / Grant | 50,000 | — | — | 285,000 | Jan 1, 2018 |
| Harvey Jimmie | — | Award / Grant | 100,000 | — | — | 450,000 | Jan 1, 2018 |
| LOBELL J JAY | — | Award / Grant | 100,000 | — | — | 786,000 | Jan 1, 2018 |
| Rowinsky Eric K | — | Award / Grant | 100,000 | — | — | 450,000 | Jan 1, 2018 |
| WEISS MICHAEL S | EXECUTIVE VICE CHAIRMAN | Award / Grant | 164,473 | — | — | 8,752,071 | Jan 1, 2018 |